CHM, >> CTIX <<
I'm not that familiar with their previous financing arrangements with Aspire. It could be that additional financing is already pre-arranged and CTIX can just get the money when they want, but it's generally not a great idea for a bio stock to let the cash get this low.
I have no position in the company and am just following it loosely to see what happens with the defensin mimetics platform. After Polymedix's icy brush with bankruptcy, I figure these bio stocks are best left in the 'entertainment' category, lol.